The newborn feels pain and the newborn at the end of life, in the delivery room, is potentially exposed to pain and respiratory distress. Protocols for the management of end-of-life symptoms in the delivery room are used in current practice with very few validation studies. The protocol used in delivery rooms in Alsace uses fentanyl and midazolam intranasally. It has been used for 3 years and seems to provide satisfactory relief to newborn babies. In doing so, it seems to reassure parents about the quality of support and it seems to meet the expectations of professionals in these anxiety-provoking contexts. Scientific validation of these practices would allow wider dissemination to other maternity teams.
Study Type
OBSERVATIONAL
Enrollment
100
Application of the care protocol and data collection
Service de médecine et Réanimation du Nouveau-né - CHU de Strasbourg -France
Strasbourg, Les Hôpitaux Universitaires de Strasbourg, France
Service de pédiatrie - Hôpitaux Civils de Colmar
Colmar, France
Service de pédiatrie - Hôpitaux Civils de Haguenau
Haguenau, France
Service de Néonatologie- Centre Hospitalier de Mulhouse
Mulhouse, France
Change in pain
Evaluate the effectiveness of the current protocol for the management of pain and discomfort related to end-of-life respiratory distress in newborns receiving palliative care in the delivery room with (Neonatal Facial Coding System) NFCS score
Time frame: 1 day
DRFV scores
Presence of DRFV with Silverman score
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.